These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7649252)

  • 1. The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3.
    Sotiropoulos A; Moutoussamy S; Binart N; Kelly PA; Finidori J
    FEBS Lett; 1995 Aug; 369(2-3):169-72. PubMed ID: 7649252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
    Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
    Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins.
    Hackett RH; Wang YD; Larner AC
    J Biol Chem; 1995 Sep; 270(36):21326-30. PubMed ID: 7673169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
    Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
    Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter.
    Wood TJ; Sliva D; Lobie PE; Goullieux F; Mui AL; Groner B; Norstedt G; Haldosén LA
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):69-81. PubMed ID: 9220023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic sequences of the growth hormone receptor necessary for signal transduction.
    Goujon L; Allevato G; Simonin G; Paquereau L; Le Cam A; Clark J; Nielsen JH; Djiane J; Postel-Vinay MC; Edery M
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):957-61. PubMed ID: 8302873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells.
    Barclay JL; Anderson ST; Waters MJ; Curlewis JD
    Mol Endocrinol; 2007 Oct; 21(10):2503-15. PubMed ID: 17609438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
    Freeth JS; Silva CM; Whatmore AJ; Clayton PE
    Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
    Silva CM; Lu H; Day RN
    Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
    Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
    Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
    Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
    Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-independent dimerization of GH receptor by a leucine zipper results in constitutive activation.
    Behncken SN; Billestrup N; Brown R; Amstrup J; Conway-Campbell B; Waters MJ
    J Biol Chem; 2000 Jun; 275(22):17000-7. PubMed ID: 10828073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
    Wang X; Darus CJ; Xu BC; Kopchick JJ
    Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling.
    Tiulpakov A; Rubtsov P; Dedov I; Peterkova V; Bezlepkina O; Chrousos GP; Hochberg Z
    J Clin Endocrinol Metab; 2005 Jan; 90(1):542-7. PubMed ID: 15536163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA; Lindberg K; Hilton DJ; Nielsen JH; Billestrup N
    Mol Endocrinol; 1999 Nov; 13(11):1832-43. PubMed ID: 10551777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
    Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.